Poor outcome for Japanese IVD (in vitro diagnostic) sales in 1998
This article was originally published in Clinica
Sales of laboratory and rapid in vitro diagnostic (IVD) tests in Japan declined in 1998 for the second consecutive year to Yen 246,185 million ($2,137 million), a 3.7% decrease from ¥55,773 million in 1997. Sales of over-the-counter (OTC) tests, including pregnancy test kits, also dropped by 14.8% to Yen3,555 million.
You may also be interested in...
Lannett will launch a further seven products in fiscal 2021, after launching four products recently in the first quarter of FY21. The company also plans to pay off its Term Loan ‘A’ in full, by the end of November 2020.
Pfizer has now received a formal European Commission approval for its Nyvepria biosimilar pegfilgrastim. The approval puts the firm in direct competition with several other versions of the Neulasta original.
AstraZeneca's research head admits that the half dose approach was a lucky mistake – but one that could boost the vaccine's effectiveness and supplies. The US regulator may not be persuaded, however.